KATHERINE GRASSO: Open Payments
NPI 1184093106 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,622 in 73 payments from 17 companies in 2025. Trend: 2023 $877 · 2024 $1,344 · 2025 $1,622
Food & beverage: $1,622
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $347 |
| ABBVIE INC. | 19 | $278 |
| Gilead Sciences, Inc. | 2 | $155 |
| Mallinckrodt Hospital Products Inc. | 2 | $154 |
| GENZYME CORPORATION | 5 | $112 |
| PFIZER INC. | 6 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $99 |
| Madrigal Pharmaceuticals | 5 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| Ardelyx, Inc. | 3 | $54 |
Products named: TREMFYA, RINVOQ, TERLIVAZ, DUPIXENT, Epclusa, ENTYVIO, REZDIFFRA, XIFAXAN.
Industry payments across NJ — which companies pay providers there.
